Filtered By:
Infectious Disease: COVID-19
Management: Health Insurance

This page shows you your search results in order of date.

Order by Relevance | Date

Total 755 results found since Jan 2013.

Risk Factors for the Prescription of Ineffective Antiviral Candidates for COVID-19 During the Early Pandemic Period in Korea
CONCLUSION: Ineffective antiviral agents were prescribed to a substantial number of patients during the first year of the COVID-19 pandemic in Korea. Treatment with these ineffective drugs tended to be prolonged in severely ill patients and in primary and public hospitals.PMID:37698205 | PMC:PMC10497349 | DOI:10.3346/jkms.2023.38.e280
Source: J Korean Med Sci - September 12, 2023 Category: General Medicine Authors: Eunyoung Lee Seungyeon Kim Sun Young Lee Joo Jeong Jihwan Bang Juhwan Oh Sang Do Shin Nam Joong Kim Pyoeng Gyun Choe Myoung-Don Oh Source Type: research

Health insurance, labor market shocks, and mental health during the first year of the COVID-19 crisis
Econ Hum Biol. 2023 Aug 23;51:101298. doi: 10.1016/j.ehb.2023.101298. Online ahead of print.ABSTRACTWe use the Census Household Pulse Survey (HPS) to examine employment and earnings loss, health insurance, and hardships related to physical and mental health and health care, as well as food insecurity and difficulty meeting expenses, during the first year of the COVID-19 pandemic. Pandemic job loss is strongly associated with uninsurance in the HPS. Moreover, among those who were not employed due to a pandemic economic reason such as a business closure, we find substantial regression-adjusted differences in hardship by insu...
Source: Economics and Human Biology - September 2, 2023 Category: Biology Authors: Sanders Korenman Rosemary T Hyson Source Type: research

Self-reported barriers to screening breast MRI among women at high risk for breast cancer
CONCLUSIONS: High-risk women reported low uptake of screening breast MRI, indicating a gap in guideline-concordant care. Breast cancer knowledge and screening-supportive social norms are two key areas to target in future interventions. Data were collected during the COVID-19 pandemic and generalizability of results is unclear. Future studies with larger, more heterogeneous samples are needed to replicate these findings.PMID:37640965 | DOI:10.1007/s10549-023-07085-w
Source: Cancer Control - August 28, 2023 Category: Cancer & Oncology Authors: Claire C Conley Jennifer D Rodriguez McKenzie McIntyre Naomi C Brownstein Bethany L Niell Suzanne C O'Neill Susan T Vadaparampil Source Type: research

COVID-19 Vaccination Status Among Korean Pediatric Population With Comorbidities
J Korean Med Sci. 2023 Aug 14;38(32):e248. doi: 10.3346/jkms.2023.38.e248.ABSTRACTThe pediatric population with comorbidities is a high-risk group for severe coronavirus disease 2019 (COVID-19). As of January 2023, the COVID-19 vaccination rate for at least two doses among Korean children 5-11 years is low at 1.1%. We summarized the COVID-19 vaccination status for the pediatric population (5-17 years) with comorbidities through July 2022 using the National Health Insurance Service database. Pediatric patients with comorbidities had higher vaccination rates than the general pediatric population (2.4% vs. 1.1% in 5-11-year-o...
Source: J Korean Med Sci - August 15, 2023 Category: General Medicine Authors: Areum Shin Dong Wook Kim Young-Eun Kim Doo Ri Kim Jaehun Jung Yae-Jean Kim Source Type: research